Dara Wright - Sep 1, 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Executive Vice President
Signature
/s/ Dara Wright
Stock symbol
BIO
Transactions as of
Sep 1, 2023
Transactions value $
-$185,857
Form type
4
Date filed
9/6/2023, 01:08 PM
Previous filing
Dec 19, 2022
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +520 +28.97% $0.00 2.31K Sep 1, 2023 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$71K -180 -7.78% $394.60 2.13K Sep 1, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +405 +18.97% $0.00 2.54K Sep 1, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$55.6K -141 -5.55% $394.60 2.4K Sep 1, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +433 +18.05% $0.00 2.83K Sep 2, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$59.2K -150 -5.3% $394.60 2.68K Sep 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +3.01K $0.00 3.01K Sep 1, 2023 Bio-Rad A Common Stock 3.01K $0.00 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -520 -24.98% $0.00 1.56K Sep 1, 2023 Bio-Rad A Common Stock 520 $0.00 Direct F3, F5
transaction BIO Restricted Stock Units Options Exercise $0 -405 -33.31% $0.00 811 Sep 1, 2023 Bio-Rad A Common Stock 405 $0.00 Direct F3, F6
transaction BIO Restricted Stock Units Options Exercise $0 -433 -49.94% $0.00 434 Sep 2, 2023 Bio-Rad A Common Stock 433 $0.00 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 14.0360 and 18.9240 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023 and 06/30/2023.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5 On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7 On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.